Table 3.

Mechanisms of CD19 loss during blinatumomab treatment

Sample IDCD19 LOH or CNACD19 mutationsSum AF of CD19 mutationsCD19 RNA expression (log CPM)Summary of CD19 loss
SJBALL042232_R2 Loss of chromosome 16 p.Y259fs (c.775 T>TGT) 0.79 Normal (5.3) CD19 mutation 
p.Y259fs (c.776 A>ATTGGAGATCCC) Loss of chromosome 16 
SJALL061897_R1 Loss of chromosome 16 p.K258fs (c.773 AGTATTAT>AAAAAAA) 0.79 Normal (5.2) CD19 mutation 
Loss of chromosome 16 
SJALL061895_R1 Loss of chromosome 16 p.109fs (c.326 C>CA) 0.65 Normal (5.4) CD19 mutation 
p.Q186sp Loss of chromosome 16 
p.P278sp  
SJALL061893_R1 No p.P60del (c.179 CCTT>C) 0.73 Normal (6.1) CD19 mutation 
Allele-specific expression 
SJALL061894_R1 No p.S269* (c.806 C>A) 0.15 Low (0.4) CD19 mutation 
Allele-specific expression (low) 
SJBALL042246_R2 No None Low (0.8) Low level of CD19 expression 
SJALL061896_R1 No None Normal (6.2) CD19 wild type 
CD81 mutation 
Sample IDCD19 LOH or CNACD19 mutationsSum AF of CD19 mutationsCD19 RNA expression (log CPM)Summary of CD19 loss
SJBALL042232_R2 Loss of chromosome 16 p.Y259fs (c.775 T>TGT) 0.79 Normal (5.3) CD19 mutation 
p.Y259fs (c.776 A>ATTGGAGATCCC) Loss of chromosome 16 
SJALL061897_R1 Loss of chromosome 16 p.K258fs (c.773 AGTATTAT>AAAAAAA) 0.79 Normal (5.2) CD19 mutation 
Loss of chromosome 16 
SJALL061895_R1 Loss of chromosome 16 p.109fs (c.326 C>CA) 0.65 Normal (5.4) CD19 mutation 
p.Q186sp Loss of chromosome 16 
p.P278sp  
SJALL061893_R1 No p.P60del (c.179 CCTT>C) 0.73 Normal (6.1) CD19 mutation 
Allele-specific expression 
SJALL061894_R1 No p.S269* (c.806 C>A) 0.15 Low (0.4) CD19 mutation 
Allele-specific expression (low) 
SJBALL042246_R2 No None Low (0.8) Low level of CD19 expression 
SJALL061896_R1 No None Normal (6.2) CD19 wild type 
CD81 mutation 

CNA, copy-number abnormality; CPM, count per million; LOH, loss of heterozygosity.

or Create an Account

Close Modal
Close Modal